These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 10933975

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
    Janousková O, Síma P, Kunke D.
    Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
    [Abstract] [Full Text] [Related]

  • 3. Gene therapy against an experimental glioma using adeno-associated virus vectors.
    Okada H, Miyamura K, Itoh T, Hagiwara M, Wakabayashi T, Mizuno M, Colosi P, Kurtzman G, Yoshida J.
    Gene Ther; 1996 Nov; 3(11):957-64. PubMed ID: 8940635
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D.
    Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
    [Abstract] [Full Text] [Related]

  • 5. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
    He J, Chen Y, Li H, Lu Y, Yan Y, Tan X.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149
    [Abstract] [Full Text] [Related]

  • 6. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
    Sakai Y, Kaneko S, Nakamoto Y, Kagaya T, Mukaida N, Kobayashi K.
    Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892
    [Abstract] [Full Text] [Related]

  • 7. Co-transduction of herpes simplex virus thymidine kinase gene and human interleukin-2 gene into mouse ovarian cancer cell line, OVHM.
    Yamaguchi Y, Takashima I, Hihara J, Ohta K, Shimizu K, Minami K, Yoshida K, Toge T.
    Int J Mol Med; 2000 Aug; 6(2):185-90. PubMed ID: 10891564
    [Abstract] [Full Text] [Related]

  • 8. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S.
    Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
    [Abstract] [Full Text] [Related]

  • 9. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO.
    Cancer Gene Ther; 1996 Jul; 3(2):99-106. PubMed ID: 8729908
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
    Ramesh R, Munshi A, Abboud CN, Marrogi AJ, Freeman SM.
    Cancer Gene Ther; 1996 Jul; 3(6):373-84. PubMed ID: 8988840
    [Abstract] [Full Text] [Related]

  • 13. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
    Zhao Y, Zhang X, Hui H.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
    [Abstract] [Full Text] [Related]

  • 14. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
    Yamamoto S, Suzuki S, Hoshino A, Akimoto M, Shimada T.
    Cancer Gene Ther; 1997 Jun; 4(2):91-6. PubMed ID: 9080117
    [Abstract] [Full Text] [Related]

  • 15. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
    Gao Ding Cheng, An W, Dai J.
    Cell Res; 1999 Sep; 9(3):225-35. PubMed ID: 10520605
    [Abstract] [Full Text] [Related]

  • 16. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ, Gore M, Smiley WR, Kanemitsu MY, Jolly DJ, Read SB, Nicholas T, Kruse CA.
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [Abstract] [Full Text] [Related]

  • 17. Long-term survival of immunocompetent rats with intraperitoneal colon carcinoma tumors using herpes simplex thymidine kinase/ganciclovir and IL-2 treatments.
    Coll JL, Mesnil M, Lefebvre MF, Lancon A, Favrot MC.
    Gene Ther; 1997 Nov; 4(11):1160-6. PubMed ID: 9425438
    [Abstract] [Full Text] [Related]

  • 18. [Combination therapy of murine liver cancer with IL-12 gene and HSV-TK gene].
    Tang Z, Sun W, Chen S.
    Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):332-5. PubMed ID: 11776567
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Killing effects of ganciclovir on human pulmonary adenocarcinoma cell A549 transduced with HSV1-TK gene in vitro and in vivo.
    He XL, Guo XJ, Qian GS, He XH, Huang GJ, Chen WZ, Li SP.
    Acta Pharmacol Sin; 2001 Oct; 22(10):901-6. PubMed ID: 11749772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.